A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males - PubMed (original) (raw)
A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males
I Meloni et al. Am J Hum Genet. 2000 Oct.
Abstract
Heterozygous mutations in the X-linked MECP2 gene cause Rett syndrome, a severe neurodevelopmental disorder of young females. Only one male presenting an MECP2 mutation has been reported; he survived only to age 1 year, suggesting that mutations in MECP2 are male lethal. Here we report a three-generation family in which two affected males showed severe mental retardation and progressive spasticity, previously mapped in Xq27.2-qter. Two obligate carrier females showed either normal or borderline intelligence, simulating an X-linked recessive trait. The two males and the two obligate carrier females presented a mutation in the MECP2 gene, demonstrating that, in males, MECP2 can be responsible for severe mental retardation associated with neurological disorders.
Figures
Figure 1
Segregation of the mutation in the family; 3% agarose gel of _Avr_II-digested PCR products of segment D of exon 3 (396 bp) obtained as reported elsewhere (De Bona et al. 2000). The C→T transition in position 1216 creates the “ccTagg” _Avr_II restriction site from the normal “cccagg” sequence, generating two fragments of 213 and 183 bp. Line 1, molecular weight marker VI (Roche), following lines as reported in pedigree above; ND = nondigested control.
Figure 2
Quantitative RT-PCR of total RNA from lymphoblastoid cells of patient (OE) and male (XY) and female (XX) controls. Primers were MECP-2 RT-S: 5′-CGC TCC ATC ATC CGT GAC-3′; MECP-2 RS-A: 5′-TCT GCC AGT TCC TGG AGC-3′; GAPDH-F: 5′-AAC ACA GTC CAT GCC ATC AC-3′; GAPDH-R: 5′-TCC ACC ACC CTG TTG CTG TA-3′. The RT was done with (+) and without (−) retrotranscriptase, as described elsewhere (Bione et al. 1996), using 1 μg of total RNA. We amplified 2.5 μl of the RT reaction in a 50-μl PCR reaction. C = PCR control without template DNA. PCR conditions were the following: GAPDH: 5 min at 94°C; 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C for 25 cycles; MECP-2: 5 min at 94°C; 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C for 35 cycles.
Figure 3
Results of X-inactivation assay: 6% polyacrylamide silver-stained gel of PCR product of CAG repeat of the androgen-receptor gene (Allen et al. 1992) from _Hpa_II digested (D) and nondigested (ND) DNA of the carrier females. Primers used for PCR amplification were RS-6: 5′-GTC CAA GAC CTA CCG AGG AG-3′ and RS-7: 5′-CCA GGA CCA GGT AGC CTG TG-3′. Band intensities were measured by Diversity Database program (Biorad), and the values were corrected for preferential allele amplification (Pegoraro et al. 1994). Results showed a balanced X-inactivation: ∼56% of X-bearing allele b active (b) and 44% of X-bearing allele a active (a) in the mother (right panel); ∼60% of normal paternal X active (c) and 40% of mutated X active (a) in the daughter (left panel).
Similar articles
- Expanding phenotype of p.Ala140Val mutation in MECP2 in a 4 generation family with X-linked intellectual disability and spasticity.
Lambert S, Maystadt I, Boulanger S, Vrielynck P, Destrée A, Lederer D, Moortgat S. Lambert S, et al. Eur J Med Genet. 2016 Oct;59(10):522-5. doi: 10.1016/j.ejmg.2016.07.003. Epub 2016 Jul 25. Eur J Med Genet. 2016. PMID: 27465203 - MECP2 mutation in male patients with non-specific X-linked mental retardation.
Orrico A, Lam C, Galli L, Dotti MT, Hayek G, Tong SF, Poon PM, Zappella M, Federico A, Sorrentino V. Orrico A, et al. FEBS Lett. 2000 Sep 22;481(3):285-8. doi: 10.1016/s0014-5793(00)01994-3. FEBS Lett. 2000. PMID: 11007980 - Rethinking the fate of males with mutations in the gene that causes Rett syndrome.
Schanen C. Schanen C. Brain Dev. 2001 Dec;23 Suppl 1:S144-6. doi: 10.1016/s0387-7604(01)00340-0. Brain Dev. 2001. PMID: 11738861 Review. - Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease.
Villard L, Lévy N, Xiang F, Kpebe A, Labelle V, Chevillard C, Zhang Z, Schwartz CE, Tardieu M, Chelly J, Anvret M, Fontès M. Villard L, et al. J Med Genet. 2001 Jul;38(7):435-42. doi: 10.1136/jmg.38.7.435. J Med Genet. 2001. PMID: 11432961 Free PMC article. - The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
Hammer S, Dorrani N, Dragich J, Kudo S, Schanen C. Hammer S, et al. Ment Retard Dev Disabil Res Rev. 2002;8(2):94-8. doi: 10.1002/mrdd.10023. Ment Retard Dev Disabil Res Rev. 2002. PMID: 12112734 Review.
Cited by
- MECP2-related disorders while gene-based therapies are on the horizon.
Allison K, Maletic-Savatic M, Pehlivan D. Allison K, et al. Front Genet. 2024 Feb 12;15:1332469. doi: 10.3389/fgene.2024.1332469. eCollection 2024. Front Genet. 2024. PMID: 38410154 Free PMC article. Review. - Research models of neurodevelopmental disorders: The right model in the right place.
Damianidou E, Mouratidou L, Kyrousi C. Damianidou E, et al. Front Neurosci. 2022 Oct 20;16:1031075. doi: 10.3389/fnins.2022.1031075. eCollection 2022. Front Neurosci. 2022. PMID: 36340790 Free PMC article. Review. - The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models.
Mapelli L, Soda T, D'Angelo E, Prestori F. Mapelli L, et al. Int J Mol Sci. 2022 Mar 31;23(7):3894. doi: 10.3390/ijms23073894. Int J Mol Sci. 2022. PMID: 35409253 Free PMC article. Review. - Report of a novel missense mutation in the MECP2 gene in a middle-aged man with intellectual disability syndrome.
Arvio M, Haanpää M, Pohjola P, Lähdetie J. Arvio M, et al. Clin Case Rep. 2021 Aug 21;9(8):e04602. doi: 10.1002/ccr3.4602. eCollection 2021 Aug. Clin Case Rep. 2021. PMID: 34457282 Free PMC article. - Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth.
Lozovaya N, Nardou R, Tyzio R, Chiesa M, Pons-Bennaceur A, Eftekhari S, Bui TT, Billon-Grand M, Rasero J, Bonifazi P, Guimond D, Gaiarsa JL, Ferrari DC, Ben-Ari Y. Lozovaya N, et al. Sci Rep. 2019 Jun 25;9(1):9276. doi: 10.1038/s41598-019-45635-9. Sci Rep. 2019. PMID: 31239460 Free PMC article.
References
Electronic-Database Information
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for the MECP2 gene [MIM <300005>] and Rett syndrome [MIM <312750>])
References
- Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670–679 - PubMed
- Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188 - PubMed
- Bienvenu T, Carrie A, de Roux N, Vinet MC, Jonveaux P, Couvert P, Villard L, Arzimanoglou A, Beldjord C, Fontes M, Tardieu M, Chelly J (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 9:1377–1384 - PubMed
- Bione S, D'Adamo D, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12:385–389 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases